Method of regulating CSF drainage

• US 9,072,865 B2
• Filed: 03/13/2009
• Issued: 07/07/2015
• Est. Priority Date: 03/14/2008
• Status: Active Grant

• Current Assignee: Sophysa
• Original Assignee: Sophysa
• Inventors: Negre, Philippe, Moureaux, Christophe, Boyer, Christophe, Bonnal, Olivier
• Primary Examiner(s): HAND, MELANIE JO
• Application Number:
  US12/921,501
• Publication Number:
  US 20110275976A1
• Time in Patent Office: 2,307 Days
• Field of Search: 604 8- 10
• US Class Current: 1/1
• CPC Class Codes: A61M 2205/3379 Masses, volumes, levels of fluids in reservoirs, flow rates
• CPC Class Codes: A61M 27/006 Cerebrospinal drainage; Accessories therefor, e.g. valves
• CPC Class Codes: G01F 1/68 by using thermal effects

Abstract

An implantable drainage device for draining the cerebro-spinal fluid of a patient, the device including:

• a drainage valve including a valve member and a valve seat;
• a control unit suitable for modifying an operating parameter of said valve, at least as a function of a measurement (D) of the fluid flow rate through said valve;
• an actuator controlled by the control unit, suitable for modifying the operation of said valve as a function of said operating parameter as modified by the control unit; and
• a mass flowmeter suitable for evaluating said flow rate of fluid through said valve.

Claims

1. An implantable drainage device for draining a patient'"'"'s cerebro-spinal fluid, the device comprising:

a drainage valve comprising a valve member and a valve seat;

a control unit suitable for modifying an operating parameter of said valve, at least as a function of a measurement (D) of the fluid flow rate through said valve, said control unit being also suitable for re-evaluating a setpoint flow rate (D*) at regular intervals and/or following a particular event; and

an actuator controlled by the control unit, suitable for modifying the operation of said valve as a function of said operating parameter as modified by the control unit;

the device including a mass flowmeter suitable for taking said measurement of said flow rate of fluid through said valve.

2. A device according to claim 1, the mass flowmeter being a thermal flowmeter.

3. A device according to claim 1, the control unit including a regulator suitable for controlling the actuator so that the measured flow rate is servo-controlled on the setpoint flow rate (D*).

4. A device according to claim 1, the setpoint flow rate (D*) being re-evaluated every hour and/or immediately after the device is implanted in the patient'"'"'s body and/or in the event of an abnormal flow rate being detected.

5. A device according to claim 1, the mass flowmeter taking measurements (D) of the flow rate in intermittent manner.

6. A device according to claim 1, the mass flowmeter taking measurements (D) of the flow rate solely during drainage stages.

7. A device according to claim 1, the control unit being suitable for modifying the operation of the valve when the flow rate measurement (D) moves out of an optimum accuracy range of the flowmeter and/or a safe range beyond which there exists a particular risk for the patient.

8. A device according to claim 3, the setpoint flow rate (D*) being settable, manually or by the control unit at regular intervals or following the detection of a need, to a value that is less than or equal to the value corresponding to the real production of cerebro-spinal fluid by the patient'"'"'s body.

9. A device according to claim 1, the control unit being configured, during a cleaning stage, to cause the valve member to be spaced apart from the seat of the drainage valve by at least 0.5 mm.

10. A device according to claim 9, wherein the control unit causes a cleaning stage to be performed in the event of an abnormal flow rate being detected or at the request of a person, or at regular time intervals.

11. A device according to claim 9, wherein the control unit causes at least one cleaning stage to be performed per week.

12. A device according to claim 9, the duration of a cleaning stage being not less than 5 seconds.

13. A device according to claim 1, the control unit being configured in such a manner as to close the drainage valve completely in the event of the flowmeter detecting a reversal of the flow direction of cerebro-spinal fluid through the drainage valve.

14. A device according to claim 1, the drainage valve being a progressive valve or an on/off valve, and the actuator acting on the valve member of the drainage valve via resilient return safety means, the return force exerted by said resilient return safety means being determined so as to cause a safety opening to occur when the pressure difference (P_d) from upstream to downstream across the seat of the drainage valve exceeds a safe pressure (P_s).

15. A device according to claim 14, the safe pressure (P_s) being greater than or equal to 250 mm H₂O.

16. A device according to claim 1, the actuator comprising a motor suitable for holding the valve member in position without being powered.

17. A device according to claim 16, wherein the actuator is a motor of the piezoelectric type or the electrostatic type.

18. A device according to claim 1, including communication means implementing a radio frequency link and suitable for receiving and/or sending control instructions from or to the exterior of the patient'"'"'s body.

19. A drainage system comprising:

a device according to claim 1 and including communication means for communicating with the exterior of the patient'"'"'s body; and

a non-implantable control unit suitable for communicating with said communication means after said device has been implanted.

20. A method of controlling a valve of an implantable drainage device for draining the cerebro-spinal fluid of a patient, the device being the device according to claim 1, the method comprising:

a regulation, the regulation being performed by means of a regulator controlling the actuator so that the measured flow rate is servo-controlled on the setpoint flow rate (D*), the setpoint flow rate (D*) being defined to a value that is less than the value needed for compensating exactly production of cerebro-spinal fluid by the patient.